Analyst Ratings for Immuneering Corporation (IMRX)
IMRX Rating Summary
IMRX Price Target Summary
- Highest: $30.00 (Oppenheimer)
- Lowest: $11.00 (Needham)
- Average: $15.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.67 (+223%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$15.67 (+223%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2026 | H.C. Wainwright » Updated 8/27/2026 |
Andres Maldonado | New Coverage | Buy (N/A) |
14.00 (N/A) |
4.39 (4.85) |
10.48% | Details |
| 7/8/2026 | Cantor Fitzgerald | Li Watsek | New Coverage | Overweight (N/A) |
N/A (N/A) |
5.10 (4.85) |
-4.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
